Nov 11O8.59H8.59L8.08C8.42Vol3.890M
Sellas Life Sciences Group Inc stock is traded at $8.42, with a volume of 3,889,938. It is up +0.60% in the last 24 hours and down -29.42% over the past month. SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Previous Close:
$8.37
Open:
$8.59
24h Volume:
3,889,938
Relative Volume:
0.55
Market Cap:
$1.70B
Revenue:
-
Net Income/Loss:
-$29.46M
P/E Ratio:
-
EPS:
-$0.2283
Net Cash Flow:
-$28.17M
1W Performance:
+6.85%
1M Performance:
-29.42%
6M Performance:
+61.30%
1Y Performance:
+465.10%
1-Day Range:
$8.08$8.59
1-Week Range:
$7.14$8.87
52-Week Range:
$1.39$15.88
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Name
Sellas Life Sciences Group IncSector
HealthcareIndustry
BiotechnologyPhone
(646) 200-5278Address
7 TIMES SQUARE, NEW YORK, NY, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS